Key highlights
Explore more by category
Showing: 1 – 10 of 45 stories
09 February 2023 – 1 mins read
Ipsen FY/Q4 2022 results–A word from CEO David Loew
Hear what Ipsen CEO David Loew has to say about our strong full year and Q4 2022 results.
05 January 2023 – 2 mins read
J.P. Morgan Conference 2023: Ipsen shares strategy success
Ipsen leaders will attend the J.P. Morgan Healthcare Conference from January 9-12, 2023, in San Francisco, California. This event will bring together biotech companies, clinical researchers, investors and analysts from all over the world to learn about hea
20 December 2022 – 1 mins read
Living with PBC: The Person Behind the Chart
‘Invisible’ diseases like primary biliary cholangitis (PBC) can be difficult to recognise, diagnose and to manage effectively. Here Prof. Gideon Hirschfield (University of Toronto, Departments of Medicine, Immunology and Medical Sciences) and Robert Mi
03 November 2022 – 4 mins read
A Life in a Day with FOP: from Empathy to Understanding…
You can never truly understand what it’s like to live with an ultra-rare condition unless you’ve experienced it for yourself. And with this in mind, we recently embarked on a project to help healthcare professionals experience what it’s like to live
02 November 2022 – 1 mins read
Ipsen anti-corruption system certification renewed in 2022
In December 2021, Ipsen received ISO 37001 certification for its anti-corruption management systems by Eurocompliance, a certification organization dedicated to the prevention of corruption.